Jolly LLB 3 is set for a strong start at the box office as advance booking trends indicate promising numbers for the Akshay Kumar and Arshad Warsi-led courtroom comedy. The film, directed by Subhash Kapoor, has already collected Rs 62.7 lakh in pre-sales with nearly 20,000 tickets sold across limited screens in India. With additional block seats, the tally touches close to Rs 2 crore, giving the trade plenty of optimism about its first-day performance.
Advance booking for the film opened on selected screens in North India over the weekend, and the numbers are expected to rise significantly through over-the-counter ticket sales and last-minute online bookings. Industry estimates suggest Jolly LLB 3 could achieve a double-digit opening on Friday, with potential to grow further if word-of-mouth is favorable.
The third installment in the franchise brings back both the Jollies Akshay Kumar and Arshad Warsi alongside veteran actor Saurabh Shukla as Judge Tripathi. The chemistry among the trio has been a defining factor in the franchise’s appeal, combining humor, satire, and socially relevant storytelling. The trailer hinted at the central conflict revolving around land encroachment issues affecting farmers, positioning the film as another sharp social commentary wrapped in courtroom drama.
Jolly LLB 3 also stars Huma Qureshi and Amrita Rao in important roles. With its theatrical release scheduled for September 19, the film is well-timed to capitalize on the weekend rush. Trade experts believe the film’s nostalgic value, franchise strength, and Akshay-Arshad duo will drive momentum through the opening weekend. If the audience response mirrors the buzz, the film could see collections doubling on Saturday and Sunday, setting it on course for a successful run.
The legal-comedy franchise has enjoyed consistent success since its inception, with both earlier films praised for balancing humor and hard-hitting issues. With Jolly LLB 3, the makers seem to have struck the right mix of courtroom theatrics, humor, and commentary, aiming to win both critical and commercial acclaim.
